Singbao International Co Ltd
Shangya Technology Co., Ltd. engages in the generic drugs and solar power generation businesses in Taiwan and Asia. The company wholesales Chinese and Western medicines, medical equipment, and beauty and hair care products; and onrito, lixin fumitation, lufuxing film-coated, amperex film coating, leverb-coated, triton film-coated, special core stabilized, tanlipo film-coated, inhibitory film-coat… Read more
Singbao International Co Ltd (6130) - Net Assets
Latest net assets as of September 2025: NT$679.83 Million TWD
Based on the latest financial reports, Singbao International Co Ltd (6130) has net assets worth NT$679.83 Million TWD as of September 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (NT$910.96 Million) and total liabilities (NT$231.12 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | NT$679.83 Million |
| % of Total Assets | 74.63% |
| Annual Growth Rate | 10.43% |
| 5-Year Change | 72.51% |
| 10-Year Change | N/A |
| Growth Volatility | 22.46 |
Singbao International Co Ltd - Net Assets Trend (2015–2024)
This chart illustrates how Singbao International Co Ltd's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Singbao International Co Ltd (2015–2024)
The table below shows the annual net assets of Singbao International Co Ltd from 2015 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | NT$746.24 Million | -6.77% |
| 2023-12-31 | NT$800.43 Million | +3.85% |
| 2022-12-31 | NT$770.76 Million | +63.07% |
| 2021-12-31 | NT$472.66 Million | +9.27% |
| 2020-12-31 | NT$432.58 Million | +31.66% |
| 2019-12-31 | NT$328.55 Million | +26.51% |
| 2018-12-31 | NT$259.70 Million | -8.54% |
| 2017-12-31 | NT$283.94 Million | -4.56% |
| 2016-12-31 | NT$297.51 Million | -2.65% |
| 2015-12-31 | NT$305.60 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Singbao International Co Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 3146900000.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Other Components | NT$658.37 Million | 105.35% |
| Total Equity | NT$624.94 Million | 100.00% |
Singbao International Co Ltd Competitors by Market Cap
The table below lists competitors of Singbao International Co Ltd ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Streamline Health Solutions Inc
NASDAQ:STRM
|
$23.23 Million |
|
Avrupa Yatirim Holding AS
IS:AVHOL
|
$23.24 Million |
|
TDM Berhad
KLSE:2054
|
$23.24 Million |
|
Orient Paper & Industries Limited
NSE:ORIENTPPR
|
$23.25 Million |
|
Micro-X Ltd
AU:MX1
|
$23.22 Million |
|
GCL Global Holdings Ltd Ordinary Shares
NASDAQ:GCL
|
$23.22 Million |
|
QUEEN S ROAD CAPITAL INV.
F:47U
|
$23.22 Million |
|
Nara Mold & Die Co. Ltd
KQ:051490
|
$23.21 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Singbao International Co Ltd's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 682,942,000 to 624,943,000, a change of -57,999,000 (-8.5%).
- Net loss of 33,428,000 reduced equity.
- Dividend payments of 22,150,000 reduced retained earnings.
- Other comprehensive income increased equity by 8,492,000.
- Other factors decreased equity by 10,913,000.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | NT$-33.43 Million | -5.35% |
| Dividends Paid | NT$22.15 Million | -3.54% |
| Other Comprehensive Income | NT$8.49 Million | +1.36% |
| Other Changes | NT$-10.91 Million | -1.75% |
| Total Change | NT$- | -8.49% |
Book Value vs Market Value Analysis
This analysis compares Singbao International Co Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 2.23x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has decreased from 3.01x to 2.23x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2016-12-31 | NT$10.46 | NT$31.45 | x |
| 2017-12-31 | NT$10.08 | NT$31.45 | x |
| 2018-12-31 | NT$9.22 | NT$31.45 | x |
| 2019-12-31 | NT$8.95 | NT$31.45 | x |
| 2020-12-31 | NT$9.15 | NT$31.45 | x |
| 2021-12-31 | NT$15.49 | NT$31.45 | x |
| 2022-12-31 | NT$18.25 | NT$31.45 | x |
| 2023-12-31 | NT$15.42 | NT$31.45 | x |
| 2024-12-31 | NT$14.11 | NT$31.45 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Singbao International Co Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -5.35%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -17.11%
- • Asset Turnover: 0.20x
- • Equity Multiplier: 1.57x
- Recent ROE (-5.35%) is below the historical average (-3.91%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2015 | -1.18% | -1.42% | 0.73x | 1.13x | NT$-33.04 Million |
| 2016 | 0.76% | 1.25% | 0.57x | 1.07x | NT$-27.23 Million |
| 2017 | -3.63% | -12.02% | 0.19x | 1.56x | NT$-38.70 Million |
| 2018 | -9.03% | -43.66% | 0.13x | 1.59x | NT$-49.42 Million |
| 2019 | -6.45% | -25.89% | 0.11x | 2.21x | NT$-41.92 Million |
| 2020 | -9.52% | -19.50% | 0.11x | 4.33x | NT$-55.12 Million |
| 2021 | 6.87% | 31.27% | 0.19x | 1.16x | NT$-14.80 Million |
| 2022 | 0.17% | 1.50% | 0.09x | 1.22x | NT$-75.80 Million |
| 2023 | -11.72% | -34.63% | 0.24x | 1.42x | NT$-148.34 Million |
| 2024 | -5.35% | -17.11% | 0.20x | 1.57x | NT$-95.92 Million |
Industry Comparison
This section compares Singbao International Co Ltd's net assets metrics with peer companies in the Drug Manufacturers - General industry.
Industry Context
- Industry: Drug Manufacturers - General
- Average net assets among peers: $805,640,000
- Average return on equity (ROE) among peers: 10.16%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Singbao International Co Ltd (6130) | NT$679.83 Million | -1.18% | 0.34x | $23.23 Million |
| Yung Zip Chemical Ind Co Ltd (4102) | $805.64 Million | 10.16% | 0.17x | $18.43 Million |